Clinton Health Access Initiative, USA   Report issue

Academic/Hospital
Founded: Boston Massachusetts United States (2002)

Organization Overview

First Clinical Trial
2020
NCT04428307
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinton Health Access Initiative, USA

Active Ingredients

Drugs in Other Trials (1)

artemisinin (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1